Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
3.985
0.00 (0.00%)
Jun 20, 2025, 9:40 AM - Market open
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $258.69 million as of June 20, 2025. Its market cap has decreased by -13.05% in one year.
Market Cap
258.69M
Enterprise Value
220.87M
1-Year Change
-13.05%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $258.69M, a decrease of -27.40%. That is a compound annual growth rate of -6.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 258.69M | 45.38% |
| Dec 31, 2024 | 177.95M | -32.37% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |